Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

Summit Completes Initial 24 Weeks Of Dosing Of Ezutromid In Patients With Dmd In Phaseout Dmd Clinical Trial

Summit Continues to Expect 24-week Data Q1 2018, which Could Provide Potential Proof of Mechanism for Ezutromid

Read the rest of entry »

OBN Celebrates Successful Inaugural BioSeed® Conference Supporting Innovative Life Sciences Companies’ Accessing Seed Funding

BioSeed® has been designed to provide a platform for innovative life science companies to present and meet with sector specific early stage investors.

Read the rest of entry »

Bonesupporttm - Cerament® G’s Potential To Prevent And Manage Biofilm-Related Bobonesupporttm - Cerament® G’s Potential To Prevent And Manage Biofilm-Related Bone Infections Highlighted In New High-Profile Publication Ne Infections Highlighted In New High

An emerging leader in innovative injectable bio-ceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery based on its unique CERAMENT® platform, announces the publication of a paper highlighting the anti-biofilm activity of CERAMENT®

Read the rest of entry »

Pertinax Pharma appoints Nigel Brooksby as Chairman

Former chairman of Sanofi to help drive the commercialization of Pertinax®

Read the rest of entry »

Replimune Announces First Patients Dosed in a a Phase 1/2 Clinical Trial of it's RP1 Oncology Immunotherapy in Patients with Advanced Solid Tumors

Study to evaluate safety and efficacy as monotherapy and in combination with anti-PD-1 checkpoint blockade

Read the rest of entry »

HVEM Products for Immuno-Oncology Research

AMSBIO has introduced a new range of Herpes Virus Entry Mediator (HVEM) products for use in immuno-oncology research.


Read the rest of entry »

Wickham Labs to attend Pharmig 2017

Wickham Laboratories will exhibit at Pharmig’s 25th Annual Event in the Crowne Plaza Heythrop Park Hotel, November 29th & 30th 2017.

Read the rest of entry »

Glyn Edwards MBE Joins OxSonics’ Board as Non-Executive Director

OxSonics Limited, a world leader in the development of ultrasound-based drug delivery systems for the treatment of cancer patients, today announced that Glyn Edwards is to join the board as Non-Executive Director.

Read the rest of entry »

Summit Highlights Utrophin Modulation as a Potential Universal Treatment Option in DMD at Action Duchenne

New Preclinical Data Show Utrophin's Positive Effect on Mitochondria Improving Muscle Health in DMD Model

Read the rest of entry »

Macrophage Pharma Limited Presents Data on Lead Immuno-Oncology Programme at 32nd Annual Society for Immunotherapy of Cancer (SITC) Conference

Macrophage Pharma Presents Data on Lead Immuno-Oncology Programme at SITC Conference - validating  ESM™ technology platform 

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.

OBN Noticeboard

This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc.  Just drop an email to us,, and we will post.